<DOC>
	<DOCNO>NCT02186704</DOCNO>
	<brief_summary>The primary aim `` Sensing Atrial High Rate Episodes DX System Implantable Cardioverter Defibrillators Trial '' ( SENSE Trial ) ass efficacy implantable cardioverter-defibrillator ( ICD ) lead dedicate atrial sensing dipole detect atrial high rate episode . The study hypothesis ICD system lead dedicate atrial sensing dipole diagnostic yield comparable standard dual chamber ICD system superior standard single chamber ICD system .</brief_summary>
	<brief_title>Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial ( The SENSE Trial )</brief_title>
	<detailed_description>The SENSE Trial design study efficacy DX System detection atrial high rate episode ( AHREs ) subject prior history atrial fibrillation . The DX System , `` DX , '' consist Biotronik DX ICD , Biotronik Linox Smart S DX lead FDA approve ICD system incorporate use implantable cardioverter-defibrillator ( ICD ) lead dedicate atrial sensing dipole . The SENSE Trial conduct 8-12 U.S. site . The lead coordinate site Weill Cornell Medical College . Subjects follow 1 year assess primary endpoint trial .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Fulfills standard indication ICD implantation Subject legally authorize representative provide write authorization per institutional requirement Subject intend implanted complete Biotronik DX system ( consist Biotronik Ilesto 7 VRT DX ICD future FDA approve Lumax VRT DX ICD , Biotronik Linox Smart S DX lead ) , implant complete Biotronik DX system 30 day prior date consent Able comply Home Monitoring Subject prior diagnosis atrial fibrillation atrial flutter Subject need atrial pacing Subject unwilling unable give inform consent participate followup Subject unable comply Home Monitoring Subject pregnant Subject le one year estimate life expectancy Subject implant cardiac device capable detecting AHREs prior implantation Biotronik DX system Subject implant Biotronik DX system AHRE detection enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Implantable Defibrillators</keyword>
	<keyword>Implanted Electrodes</keyword>
</DOC>